Lotte Biologics to invest $3B to build three plants in South Korea

Lotte Biologics will invest $3 billion to build a bio industrial complex with three plants in South Korea by 2030, with annual capacity of 360,000 liters of antibody drugs. The first plant is scheduled for commercial production from 2027.

“Lotte Biologics will invest $3 billion to build a bio industrial complex that will house three plants with an annual production capacity of 360,000 liters of antibody drugs in South Korea by 2030.”pulse.mk.co.kr

• 1 source
• pulse.mk.co.krLotte Biologics to invest $3 bn to build 3 plants by 2030 - 매일경제 영문뉴스 펄스(Pulse)Jan 11, 2023

Summarized from public sources; check the original articles before acting on it.